Skip to main content

Advertisement

SpringerLink
Log in

Treatment of atopic dermatitis with dupilumab in Taiwan: dynamic changes of IgE levels as a potential response biomarker

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lan CC, Lee CH, Lu YW, et al. Prevalence of adult atopic dermatitis among nursing staff in a Taiwanese medical center: a pilot study on validation of diagnostic questionnaires. J Am Acad Dermatol 2009; 61: 806–12.

    Article  Google Scholar 

  2. Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate to severe atopic dermatitis with dupilumab and concomitant topical corticosteroid (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo controlled, phase 3 trial. Lancet 2017; 389: 2287–303.

    Article  CAS  Google Scholar 

  3. Olesen CM, Holm JG, Norreslet LB, Serup JV, Thomsen SF, Agner T. Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre. J Eur Acad Dermatol Venereol 2019; 33: 1562–8.

    CAS  PubMed  Google Scholar 

  4. Yosipovich G, Papoiu AD. What causes itch in atopic dermatitis? Curr Allergy Asathma Rep 2008; 8: 306–11.

    Article  Google Scholar 

  5. Shim WH, Park HY, Kim HS, et al. Does the EASI score reflect itch severity? Ann Allergy Asthma Immunol 2011; 106: 540–1.

    Article  Google Scholar 

  6. Guttman-Yassky E, Bissonnette R, Ungar B, et al. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol 2019; 143: 155–72.

    Article  CAS  Google Scholar 

Download references

Acknowledgements and disclosures

Acknowledgements: This study was supported by the Ministry of Health and Welfare, Taiwan (MOHW106-TDU-B-212-113006; MOHW107-TDU-B-212-123006).

Author information

Authors and Affiliations

  1. Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

    Tzu Hung Huang, Yin-Chun Chen, Sheng-Yiao Lin, Szu-Hao Chiu, Ting-Ting Yang, Li-Wen Chiu, Yang-Yi Chen & Cheng-Che E. Lan

  2. Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

    Yang-Yi Chen & Cheng-Che E. Lan

  3. Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

    Cheng-Che E. Lan

Authors
  1. Tzu Hung Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yin-Chun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sheng-Yiao Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Szu-Hao Chiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ting-Ting Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Li-Wen Chiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yang-Yi Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Cheng-Che E. Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cheng-Che E. Lan.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, T.H., Chen, YC., Lin, SY. et al. Treatment of atopic dermatitis with dupilumab in Taiwan: dynamic changes of IgE levels as a potential response biomarker. Eur J Dermatol 29, 658–659 (2019). https://doi.org/10.1684/ejd.2019.3661

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2019.3661

Search

Navigation